Both tetrahydrocannabivarin (THCV) and cannabidiol (CBD) are phytochemicals similar to the active ingredient in marijuana, but without the psychoactive effects. According to a report published in the journal Diabetes Care in August 2016, both molecules could be helpful in treating high blood sugar levels in people who have been diagnosed with Type 2 diabetes.
Scientists at the University of Nottingham in Derby and several other research institutions in the UK looked at 62 participants with a Type 2 diabetes diagnosis. It was found…
- THCV decreased their fasting blood sugar levels when compared with a placebo and improved the ability of their pancreas to make insulin.
- CBD improved their insulin sensitivity and helped their pancreas to make insulin in response to their food intake.
From these results, researchers concluded both substances might be useful and safe as a treatment for Type 2 diabetes.